Adrian Levitsky | Nordic Disease Area Specialist, Oncology
BMS

Medical professional specializing in oncology in the life sciences industry. Lead in gastrointestinal cancers and pan-tumor pipeline medical touchpoint for the entire Nordic region at Bristol Myers Squibb. Experienced with bridging knowledge gaps as a scientific advisor between the industry and healthcare in a broad range of diseases, both in solid tumors and blood cancers. Enabling research and implementation of the most novel therapies from the pipeline to target a multitude of major cancers; specialized medical professional for clinical trials and indications in all phases. Industry-academia research collaboration coordinator. Researcher in oncology and rheumatology. Experienced with quantitative research and the development and assessment of usable research tools in several therapeutic areas, including clinical trials and precision medicine in oncology and rheumatology. A capable translational communicator with experience from several international scientific congresses. Headed all centralized data management activities and built the clinical database for an international multi-center, multi-randomized phase III open label prospective umbrella trial for acute lymphoblastic leukemia.  Postdoctoral research focused on complex interactions among quantified subjective factors and their prognostic capability: linking the first experience of patient symptoms and sensations through an online, interactive questionnaire with biological analyses and bio-behavioral research to aid in diagnosing lung cancer earlier with machine learning.  Doctoral research centralized on optimizing precision medicine in rheumatoid arthritis through randomized trials – focusing on prediction and outcomes of pharmaceutical therapies through individualized patient profiles with biomarkers and risk factors, and assessing integrative manual therapy for chronic pain. A passion for precision medicine: finding the right medicine for the right patent.